| Size & multiples | |||
| Market Cap | €67.0M | Enterprise Value | €65.9M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 16.48× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 16.21× | EV/FCF | — |
| FCF Yield | −4.74% | Buyback Yield | — |
| Owner Earnings (TTM) | -€5.5M | Owner Earnings Yield | −8.29% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.08 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.42% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Flows latest annual · EPS TTM -€0.16 · revenue TTM €4.1M · FCF TTM -€3.2M (in EUR)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -4.7% | -7.9% | -35.6%–1.4% | 57 ↑strong |
| Net Margin | -136.6% | -21.2% | -325.3%–7.2% | 34 ↓weak |
| Operating Margin | -136.3% | -34.5% | -552.0%–8.0% | 38 ↓weak |
| ROE | -92.3% | -36.8% | -92.5%–4.5% | 25 ↓weak |
